跳至主要内容
临床试验/NCT04600934
NCT04600934撤回不适用

Shockwave Assisted Large Bore Access (TAVR, TEVAR, EVAR, FEVAR)

Medical University of South Carolina1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2022年10月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
入组人数
7
试验地点
1
主要终点
Successful advancement of planned large bore access device

研究概览

简要总结

Annually, 150-200 TAVR with unilateral large bore access and 200 combined TEVAR/EVAR/FEVAR with bilateral large bore access are performed at our institution. Nearly 50 percent of patients fall outside IFU for access vessel size. Adjuncts described include iliac conduit, crack and pave, balloon expandable sheaths, direct aortic puncture, transcaval delivery, alternative access point (i.e axillary, carotid). Each of these adjuncts comes with additional complication potential and by nature of being used less frequently than the standard femoral access makes the procedure more challenging.

The intervention the use of the Shockwave Medical, Inc. Peripheral Lithoplasty® System to achieve large bore access in patients whose vessels fall outside of the IFU suggested dimensions.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years
  • Indicated for planned procedure requiring large bore (>12 French sheath) access
  • Mental capacity to provide informed consent
  • Iliac access vessel demonstrates >50% circumferential calcium
  • Iliac access vessel demonstrates maximum inner lumen diameter less than IFU for device required
  • Iliac access vessel demonstrates maximum outer wall diameter greater than or equal to IFU for device required
  • Preoperative CT angiogram, </= 5mm slices
  • Preoperative ABI/TP
  • Unsuccessful delivery of large bore sheath without adjunctive intervention
  • o Definition of unsuccessful = operator assessment of the following
  • Visible distortion of iliac artery calcification under fluoroscopy without forward progress of device
  • Adverse forward pressure application by operator
  • Failure of device to track with external pressure applied to abdomen
  • Patient intolerance of advancement (pain response) in awake patient

排除标准

  • Contraindicated for antiplatelet therapy (aspirin or plavix)
  • Planned iliofemoral surgical reconstruction in next 30 days
  • Prior common or external iliac artery stent placement
  • Prior aorto-iliac, aorto-femoral, or iliofemoral bypass present
  • Iliac access vessel demonstrates maximum outer wall diameter less than IFU for device required
  • Inability to obtain preoperative CTA (contrast allergy, CKD, etc)
  • Inability to traverse iliac segment with wire
  • Emergent procedure

研究组 & 干预措施

Standard POBA (plain old balloon angioplasty)

Active Comparator

The first 50 patients will be pre-treated with standard POBA

干预措施: Plain old balloon angioplasty (Device)

Shockwave

Experimental

The second 50 patients will be treated primarily with Shockwave

干预措施: Shockwave (Device)

结局指标

主要结局

Successful advancement of planned large bore access device

时间窗: Day 1

Technical success-defined as successful advancement of planned large bore access device without use of additional adjuncts (stenting, repeat shockwave treatment, high pressure balloon, alternative access pathway)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mathew Wooster

Assistant Professor

Medical University of South Carolina

研究点 (1)

Loading locations...

相似试验